Rejection mechanisms in transplantation

Wiener Klinische Wochenschrift

Volumn 113, Issue 20-21, 2001, Pages 832-838

  Game, D S ^a   Warrens, A N ^a   Lechler, R I ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Allorecognition; Direct pathway; Indirect pathway; Mechanism; Rejection; Xenotransplantation

Indexed keywords

ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; DISEASE CLASSIFICATION; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE ACTIVATION; XENOTRANSPLANTATION;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MINOR HISTOCOMPATIBILITY ANTIGENS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0035976054     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Über Agglutinationserscheinungen normalen menschlichen Blutes
2. Karl Landsteiner and the first human marker locus
3. The potential supply of organ donors: An assessment of the efficacy of organ procurement efforts in the United States
4. Organ transplantation between widely disparate species
5. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
6. Characterization and affinity isolation of xenoreactive human natural antibodies
7. Evaluation of antibody synthesis in broadly sensitized patients
8. The effect of panel reactive antibodies and donor-specific cross-match on graft survival after heart and heart-lung transplantation
9. Cross-matching in liver transplantation
10. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients
11. Renal transplantation following immunoadsorption in highly sensitized recipients
12. Renal transplantation across the ABO barrier using A2 kidneys
13. Actively acquired tolerance of foreign cells
14. MHC and alloreactivity: Presentation of major and minor histocompatibility antigens
15. Migration patterns of dendritic leucocytes: Implications for transplantation
16. Mediation of acute but not chronic rejection of the incompatible rat kidney grafts by alloreactive VCD4+ cells activated by the direct pathway of sensitisation
17. Immunogenicity of retransplanted rat kidney allografts
18. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells
19. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice
20. Donor major histocompatibility complex peptides are presented by recipient MHC molecules during graft rejection
21. Indirect recognition of donor HLA-DR peptides in organ allograft rejection
22. Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts
23. Mechanisms of oral tolerance by MHC peptides
24. The alloresponse
25. Innate immunity and graft rejection
26. The role of HLA in renal transplantation
27. Risk factors for chronic rejection in renal allograft recipients
28. Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function
29. Detection of donor-specific hyporesponsiveness following late failure of human renal allografts
30. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans
31. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
32. Significant frequencies of T cells with indirect specificity in heart graft recipients with chronic rejection
33. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
34. Antigen specific interaction between T and B cells
35. The contributions of T cell anergy to peripheral T cell tolerance
36. The role of the B7 costimulatory pathway in experimental cold ischaemia/ reperfusion injury
37. Alloantibody and T-cell mediated immunity in the pathogenesis of transplant arteriosclerosis
38. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients
39. The role of transforming growth factor beta in chronic renal allograft nephropathy
40. T-cell growth factors in allograft rejection and tolerance
41. Mechanisms of chronic rejection
42. Chronic allograft nephropathy - A model of impaired repair from injury?
43. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells
44. Role of donor and recipient antigen presenting cells in priming and maintaining T cells with indirect allospecificity
45. Interleukin-2-receptor blockade with Daclizumab to prevent acute rejection in renal transplantation
46. On costimulatory signals and T cell tolerance: Relevance for transplantation immunity
47. Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection
48. Biochemical mechanisms of IL2 regulated fas-mediated T cell apoptosis
49. CD28-DB7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2
50. Chronic allograft rejection
51. Clinical xenotransplantation of solid organs
52. Xenotransplantation